Pre-qualified active aromatic isolates, volatile carriers, and therapeutic essential oils batch-tested via calibrated GC-MS.
Mechanistic analysis of 4-allyl-2-methoxyphenol across dental pulp neuroreceptors, cellular inflammatory cascades, and polymicrobial oral biofilms.
Eugenol reversibly inhibits action potential propagation along unmyelinated C-fibers and finely myelinated A-delta fibers within the human dental pulp. By directly attenuating Nav1.7 and Nav1.8 voltage-gated sodium channels, it eliminates retrograde nociceptive signal transmission to the trigeminal ganglion with an immediate localized anesthetic effect.
Irreversible acute pulpitis is characterized by elevated intra-pulpal pressure resulting from arachidonic acid metabolites. The active clove bud fraction inhibits cyclooxygenase-2 (COX-2) enzyme transcription and suppresses prostaglandin E2 (PGE2) synthesis, dampening vasodilation, interstitial edema, and pressure-induced microvascular ischemic necrosis.
Beyond analgesia, high-grade clove oil demonstrates wide-spectrum bactericidal potency against key oral pathogens: Streptococcus mutans, Porphyromonas gingivalis, and Enterococcus faecalis. Lipophilic phenolics permeate bacterial phospholipid bilayers, dissipating the proton motive force and triggering cellular lysis without driving antimicrobial resistance.
Genuine pharmaceutical-grade clove oil extracted from the flower buds of Syzygium aromaticum contains a strictly balanced ratio of 85.0% - 92.0% Eugenol, 5.0% - 12.0% Eugenyl Acetate, and <4.0% Beta-Caryophyllene. Deviations indicate stem-oil or leaf-oil adulteration which impairs chelation with zinc oxide powder in restorative cements.
Technical integration specifications across modern endodontics, restorative dentistry, oral surgeries, and fast-moving oral care cosmetics.
The global gold standard in temporary restorations. Pure eugenol undergoes an acid-base chelation reaction with zinc oxide powder, forming amorphous zinc eugenolate [Zn(C10H11O2)2]. This composite provides exceptional marginal seal, low intra-oral solubility, and sustained sedative ion release to irritated dentinal tubules.
Post-extraction complications require targeted surgical management. Eugenol-impregnated iodoform gauze or pastes act directly on denuded bone surfaces after primary blood clot breakdown, providing prolonged palliative relief and preventing secondary osteomyelitis without requiring systemic opioid analgesics.
Used alongside gutta-percha master cones during root canal obturation. Eugenol-based formulas (Grossman’s sealer) show steady viscosity during placement, prolonged working times, and controlled volumetric expansion that seals complex lateral apical deltas against periapical fluid infiltration.
Consumer formulations employ micro-encapsulated clove oil fractions (0.05% - 0.2% concentration) inside alcohol-free emulsions to neutralize volatile sulfur compounds (VSC) generated by subgingival anaerobes, supporting periodontal healing and daily halitosis control.
How Jiangxi Baicao Pharmaceutical combines direct raw feedstock cultivation, smart GMP workshops, and multi-stage fractionating rectification columns.
Operating out of the Jinggangshan Economic & Technological Development Area, our dual-workshop layout strictly separates high-volatility essential oil distillation from botanical extract dry powder lines. With 12 dedicated automated production lines, cross-contamination is eliminated, allowing for rapid batch turnarounds and scalable continuous production.
Unlike basic field distillations that cause thermal scorching and high polyphenol degradation, our plant runs advanced stainless steel high-vacuum rectification columns. This enables boiling-point separations accurate to within ±0.5°C, yielding transparent, pale-yellow clove oils with uniform viscosity and minimized trace impurities.
Every commercial consignment undergoes mandatory testing via our on-site Quality Control center. Equipped with Gas Chromatography-Flame Ionization Detection (GC-FID), Gas Chromatography-Mass Spectrometry (GC-MS), and High-Performance Liquid Chromatography (HPLC), we verify active marker concentrations and check for heavy metals and residual solvents.
Strategic analysis for enterprise chemical purchasers navigating raw harvest fluctuations across Indonesia, Madagascar, and the global processing hubs.
Global raw clove harvest outputs frequently encounter climate disruptions, erratic monsoons, and localized socio-economic volatility across East Africa and Southeast Asia. Jiangxi Baicao Pharma maintains strategic safety stockpiles and multi-origin procurement models, guaranteeing contracted pricing, predictable shipping schedules, and stable lead times.
Commodity markets often cut natural clove oils with petroleum-derived synthetic eugenol (synthesized from guaiacol) or diluted with petrochemical phthalates (DEP) and vegetable oils. Our laboratory utilizes carbon-14 (14C) isotope testing and chiral GC-MS analysis to verify 100% natural bio-botanical origin, safeguarding your brand from regulatory scrutiny.
Regulatory authorities including the EU SCCS and US FDA enforce stringent limits on methyleugenol content due to suspected hepatotoxicity at high concentrations. Our vacuum fractional separation selectively removes methyleugenol isomers down to ultra-trace levels (<0.05%), keeping consumer cosmetic formulations compliant worldwide.
Addressing the volatility, chemical degradation, and strong organoleptic taste of classical clove formulations via modern pharmaceutical technology.
By using dense-phase carbon dioxide at near-critical temperatures (31.1°C) and elevated pressure (7.39 MPa), our pilot facilities bypass thermal exposure completely. SFE-CO2 delivers clove bud extracts with authentic volatile profiles, free from residual solvents and with an aroma true to the raw botanical flower.
To eliminate the intense mucosal burning of pure essential oil drops, Baicao has engineered supramolecular inclusion complexes using beta-cyclodextrin. The lipophilic eugenol core is enclosed in a hydrophilic carbohydrate shell, yielding a water-dispersible, free-flowing dry powder for toothache tablets, oral sprays, and dry sachets.
Combining non-ionic food-grade surfactants with pharmaceutical eugenol produces self-emulsifying nano-systems (droplet size <80 nm). These transparent emulsions adhere evenly to periodontal gingival pockets, resisting saliva wash-out and providing sustained analgesic release over 6 to 8 hours.
Complete regulatory dossiers ready for pharmaceutical filing, international maritime transport (IMDG), and commercial air cargo (IATA).
We supply complete technical documentation for product registration and cross-border customs clearance: Certificate of Analysis (COA) per batch, dynamic 16-section Safety Data Sheet (SDS/MSDS according to GHS), Technical Data Sheet (TDS), Certificate of Origin (COO), and Allergen/GMO Declarations.
Volatile essential oils require protective packaging to prevent terpene autoxidation. We utilize food-grade, nitrogen-purged 25 kg fluorinated HDPE canisters, 50 kg epoxy-lined steel drums, and 180 kg / 200 kg airtight galvanized iron drums built to withstand long oceanic transport cycles.
For distributors and pharmacy brands, our Ji’an facility offers turnkey OEM private labeling. We fill and seal amber glass bottles (10 ml, 15 ml, 30 ml, 50 ml) fitted with child-resistant dropper pipettes, tamper-evident caps, and retail-ready folding cartons ready for supermarket shelves.
Essential guidance on chemical assays, safe application thresholds, documentation, and international order minimums.
Cosmetic carriers, concentrated functional extracts, and food-grade raw materials manufactured under ISO & GMP controls.